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a  b  s  t  r  a  c  t
Medicinal  health  beneﬁts  uses  of edible  as  well  as  non-edible  mushrooms  have  been  long recog-
nized.  The  pharmacological  potential  of  mushrooms,  especially  antitumor,  immunostimulatory  and
anti-inﬂammatory  activities  has  been  documented.  Wild  ectomycorrhizal  mushroom,  Lactarius  rufus  had
the  anti-inﬂammatory  and  antinociceptive  potential  of  their  polysaccharides  evaluated  using  the  forma-
lin  model.  Two  structurally  different  (1→3),(1→6)-linked  -d-glucans  were  isolated  from  fruiting  bodies.
Soluble  (FSHW)  -d-glucan  1–30  mg kg−1 produced  potent  inhibition  of inﬂammatory  pain caused  by for-eywords:
actarius rufus
1→3),(1→6)--d-Glucan
nti-inﬂammatory
ain
malin  when  compared  with  the  insoluble  one  (IHW),  suggesting  that  solubility  and/or  branching  degree
could  alter  the  activity  of -glucans.  Their  structures  were  determined  using  mono-  and  bi-dimensional
NMR  spectroscopy,  methylation  analysis,  and  controlled  Smith  degradation.  They  were  -d-glucans,  with
a  main  chain  of (1→3)-linked  Glcp  residues,  substituted  at O-6  by  single-unit  Glcp  side  chains  (IHW),  on
average  to  every  fourth  residue  of  the  backbone,  or by  mono-  and  few  oligosaccharide  side  chains  for
soluble  -glucan.
© 2013 Elsevier Ltd. Open access under the Elsevier OA license.. Introduction
Wild mushrooms have become more important in our diet
or their nutritional (Breene, 1990; Crisan & Sands, 1978; Manzi,
ambelli, Marconi, Vivanti, & Pizzoferrato, 1999), organoleptic
Maga, 1981) and pharmacological (Bobek, Ginter, Jurcovicová, &
uniak, 1991; Bobek, Ozdyn, & Kuniak, 1995; Bobek & Galbavy,
999) characteristics. Some of them can form mycorrhiza and
s they are almost the only organisms that can degrade cellu-
ose and lignin, they are indispensable in ecosystems (Gussem,
andenabeele, Verbeken, & Moens, 2005). Some ectomycorrhizal
pecies, such as Lactarius rufus, were introduced into Brazil due to
he expansion of the timber industry, with increased Eucalyptus and
inus reforestation.Regarding the mentioned species, L. rufus fruiting bodies had
ot previously been studied in relation to its content of polysaccha-
ides. Overall, those isolated from mushroom fruiting bodies can be
∗ Corresponding author. Tel.: +55 41 3361 1655; fax: +55 41 3266 2042.
E-mail  address: iacomini@ufpr.br (M.  Iacomini).
144-8617 ©  2013 Elsevier Ltd. 
ttp://dx.doi.org/10.1016/j.carbpol.2013.01.026
Open access under the Elsevier OA license.either water-soluble or/and -insoluble homo- and heteropolysac-
charides with different main- and side-chains.
Homo- and hetero--glucans with -(1→3), -(1→4) and
-(1→6) glycosidic linkages are considered the most interest-
ing functional components in mushrooms (Manzi & Pizzoferrato,
2000). Consequently there is great interest on these molecules
especially because they can act as biological response modiﬁers
(Gonzaga, Ricardo, Heatly, & Soares, 2005; Lavi, Friesem, Geresh,
Hadar, & Schwartz, 2006; Smith, Rowan, & Sulliva, 2002), and rather
than attack the harmful agent they boost the host defense mech-
anism, stimulating its intrinsic ability to resist disease-causing
invaders (Kogan, 2000). -Glucans are supposed to play a key
role in some healthy properties attributed to mushrooms, such
as enhancement of macrophage function and host resistance to
many bacterial, viral, fungal and parasitic infections and activa-
tion of a non-speciﬁc immune stimulation (Cheung, 1998; Manzi
& Pizzoferrato, 2000; Rajarathnam, Shashirekha, & Bano, 1998).The  protective action of -glucans, described as non-speciﬁc
immunomodulators, may  usually involve many different path-
ways including T-cell stimulation, increased macrophage par-
ticipation and release of different cytokines, stimulation of
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eticulo-endothelial system (RES), activation of natural killer (NK)
ells, activation of the classical and alternative complement path-
ays, increased antibody production (Kogan, 2000; Mantovani
t al., 2008).
Studies in vitro and in vivo reveal that the immunostimulating
ctivity  of -glucans depends on their structure, molecular weight
nd degree of branching (Brown & Gordon, 2003; Mantovani et al.,
008; Miura et al., 2003).
Consequently,  the isolation and structural characterization of
1→3),(1→6)-linked -d-glucans from L. rufus fruiting bodies are
ow described. Since they have differences in solubility, and dif-
erent degrees of branching, the structures were also evaluated for
ntinociceptive and anti-inﬂammatory potential in order to allow
 structure activity relationship.
.  Materials and methods
.1.  Biological material
L.  rufus (Scop.: Fr.) Fr. fruiting bodies were collected in the mid-
le of May, 2005 from soil of a Pinus sp. reforestation project located
n Mafra, State of Santa Catarina, Brazil at latitude: 26◦13′S; longi-
ude: 49◦50′W and altitude of 826 m above sea level. They were
dentiﬁed by the mycologist André A. R. de Meijer. The samples,
fter cleaning and drying in vacuo, were ground to a ﬁne pow-
er.
.2. Extraction and puriﬁcation of ˇ-glucans
Extraction of crude polysaccharides obtained from L. rufus, and
heir puriﬁcation was carried out as described in ﬂowchart Fig. 1A.
Dried, Wiley-milled powder from L. rufus fruiting bodies (42.2 g)
as submitted to successive cold (4 ◦C) and hot (∼98 ◦C) aque-
us extraction, both for 6 h (×6, 2 L and 1 L, respectively), each.
he extracted polysaccharides were recovered from aqueous
xtracts by addition to excess EtOH, giving fractions CW and
W, respectively. The crude fraction obtained from hot aque-
us extraction (HW), was submitted to a freeze-thawing process
Gorin & Iacomini, 1984) furnishing cold water-soluble (SHW) and -
nsoluble polysaccharide fractions (IHW), which were separated by
entrifugation (8000 rpm, 20 min, 5 ◦C). The water-soluble fraction
as treated with Fehling solution and the soluble fraction (FSHW)
as isolated of the insoluble Cu2+ complex, provided by centrifuga-
ion under the same conditions as described above. The respective
ractions were each neutralized with HOAc, dialyzed against tap
ater and deionized with mixed ion exchange resins and then
reeze dried (Fig. 1A).
.3.  Monosaccharide composition
Each  polysaccharide fraction (1 mg)  was hydrolyzed with 2 M
FA at 100 ◦C for 8 h, followed by evaporation to dryness. The
esidues were successively reduced with NaBH4 (1 mg)  and acety-
ated with Ac2O-pyridine (1:1, v/v; 200 L) at 100 ◦C for 30 min
ollowing the method of Sassaki et al. (2008). The resulting alditol
cetates were analyzed by gas chromatography–mass spectrom-
try (GC–MS), using a Varian model 3 300 gas chromatograph
inked to a Finnigan Ion-Trap, Model 810-R12 mass spectrome-
er. Incorporated was a DB-225 capillary column (30 m × 0.25 mm
.d.) programmed from 50 to 220 ◦C at 40 ◦C min−1, then hold, and
he alditol acetates identiﬁed by their typical retention times and
lectron impact proﬁles.olymers 94 (2013) 129– 136
2.4. Determination of homogeneity of ˇ-d-glucans and their
molecular  weight (Mw)
The  homogeneity and molar mass (Mw) of water-soluble puri-
ﬁed glucan fraction FSHW was determined by high performance
steric exclusion chromatography (HPSEC), using a refractive index
(RI) detector. The eluent was 0.1 M NaNO3, containing 0.5 g.L−1
NaN3. The solutions were ﬁltered through a membrane, with pores
of 0.22 m diameter (Millipore). The speciﬁc refractive index incre-
ment (dn/dc) was determined, using a Waters 2 410 detector, the
samples being dissolved in the eluent, ﬁve increasing concentra-
tions, ranging from 0.2 to 1.0 mg  mL−1 being used to determine the
slope of the increment.
2.5.  Methylation analysis of ˇ-glucans
Per-O-methylation of each isolated polysaccharide (10 mg)
was carried out using NaOH-Me2SO-MeI as described by Ruthes,
Komura, Carbonero, Sassaki, Gorin, and Iacomini (2010). The pro-
cess, after isolation of the products by neutralization (HOAc),
dialysis, and evaporation was  repeated, and the methylation was
found to be complete. The per-O-methylated derivatives were
hydrolyzed with 45% aqueous formic acid (1 mL) for 15 h at 100 ◦C
(Carbonero et al., 2012), followed by NaBD4 (sodium borodeu-
teride) reduction and acetylation as above (item 2.3), to give a
mixture of partially O-methylated alditol acetates, which was  ana-
lyzed by GC–MS using a CP-Sil-43CB capillary column as described
at item 2.3, and identiﬁed from m/z of their positive ions, by com-
parison with standards, the results being expressed as a relative
percentage of each component (Sassaki, Gorin, Souza, Czelusniak,
& Iacomini, 2005).
2.6.  Controlled smith degradation of ˇ-glucans
The puriﬁed glucans (IHW and FSHW; 100 mg  each) were each
submitted to oxidation with 0.05 M aqueous NaIO4 (15 mL)  at room
temperature for 72 h in the dark. Ethylene glycol was  added to stop
the reaction, the solutions dialyzed, and the resulting polyalde-
hydes were reduced with NaBH4 for 24 h, neutralized with HOAc,
dialyzed, and concentrated (Goldstein, Hay, Lewis, & Smith, 2005).
The residues were partially hydrolyzed with TFA pH 2.0 (30 min
at 100 ◦C); followed by dialysis against tap water using mem-
branes with a size exclusion of 2 kDa and the solutions containing
retained material were freeze-dried. An aliquot (40 mg)  of each
degraded fraction, SM-IHW and SM-FSHW, was submitted to 13C
NMR  spectroscopy and a sample (10 mg)  was  submitted to meth-
ylation analysis.
FSHW  (500 mg)  was  further submitted to three cycles of con-
trolled Smith degradation as described above to produce a linear
polysaccharide (SM3-FSHW) formed only by its main chain. This
was compared for biological potential to those of isolated -
glucans, IHW and FSHW.
2.7.  Nuclear magnetic resonance (NMR) spectroscopy
13C NMR  spectra were obtained using a 400 MHz  Bruker model
DRX Avance spectrometer incorporating Fourier transform. Analy-
ses were performed at 70 ◦C on samples dissolved in D2O (FSHW)
or Me2SO-d6 (IHW and SM derived fractions). Chemical shifts of
water-soluble samples are expressed in ı (ppm) relative to acetone
at ı 30.20 and 2.22 for 13C and 1H signals, respectively, and at ı
39.70 (13C) and 2.40 (1H) for those dissolved in Me2SO-d6.
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dig. 1. (A) Scheme of extraction and puriﬁcation of -glucans from L. rufus (IHW an
—) and refractive index detectors ( ).
.8. Experimental animals
Experiments  were conducted using Swiss mice of both sexes
25–35 g) provided from Universidade Federal de Santa Catarina
UFSC) facilities, were kept in an automatically controlled temper-
ture room (20 ± 2 ◦C) on a 12 h light–dark cycle (light on from 6:00
.m.), with food and water being freely available. Animals (male and
emale mice were homogeneously distributed among groups) were
cclimatized to the laboratory for at least 2 h before testing and
ere used only once for experiments. These were performed after
pproval of the protocol by the Institutional Ethics Committee of
he Universidade Federal de Santa Catarina and in accordance with
urrent guidelines for the care of laboratory animals and ethical
uidelines for investigation of experimental pain in conscious ani-
als (Zimmermann, 1983). The number of animals and intensities
f noxious stimuli used were the minimum necessary to demon-
trate consistent effects of the drug treatments.
.9. Nociception induced by intraplantar injection of formalin
The  procedure used was essentially the same as that described
reviously (Santos & Calixto, 1997). Animals received 20 L
f a 2.5% formalin solution (0.92% formaldehyde in saline),
njected intraplantarly in the ventral surface of the right hind
aw. Animals were observed from 0 to 5 min  (early phase)
nd 15–30 min  (late phase). Mice were treated with differ-
nt doses of FSHW, IHW or SM3-FSHW (1–30 mg  kg−1) by the
ntraperitoneal route 30 min  beforehand. Control animals received
 similar volume of the saline solution (10 mL  kg−1, i.p.), used to
ilute the FSHW, SM3-FSHW or vehicle (saline plus 5% Tween 80)); (B) elution proﬁle of fraction FSHW determined by HPSEC using light scattering
for fraction IHW. After the intraplantar injection of formalin, ani-
mals were immediately placed in a glass cylinder 20 cm in diameter.
The time they spent licking the injected paw was recorded with a
chronometer and considered as indicative of nociception.
2.10. Statistical analysis
The  results are presented as mean ± standard error of the mean
(SEM), except for the ID50 values (i.e., the dose of polysaccharide
necessary to reduce the nociceptive response by 50% relative to the
control value), which were reported as geometric means accompa-
nied by their respective 95% conﬁdence limits. The ID50 value was
determined by nonlinear regression from individual experiments
using linear regression GraphPad software (GraphPad software, San
Diego, CA, USA). The statistical signiﬁcance of differences between
groups was detected by ANOVA followed by Newman–Keuls’ test.
P-values less than 0.05 (p < 0.05) were considered to be indicative
of signiﬁcance.
3.  Results
3.1. Structural characterization of (1→3),(1→6)-ˇ-d-glucans
In  order to obtain pure polysaccharides from the fruiting bodies,
L. rufus was  submitted to successive cold and hot aqueous extrac-
tion at 4 ◦C (Ruthes, Rattmann, Carbonero, Gorin, & Iacomini, 2012)
and ∼98 ◦C, respectively (Fig. 1A). This report will present only
results obtained from hot aqueous extraction, once polysaccharide
fractions obtained from cold aqueous extraction are described in
a previous publication (Ruthes et al., 2012). Polysaccharides were
132 A.C.  Ruthes et al. / Carbohydrate Polymers 94 (2013) 129– 136
Table 1
Partially O-methylated acetates formed on methylation analysis of the -d-glucans obtained from L. rufus fruiting bodies: linkage types.
Partially O-methylated alditol acetatesa Rtb % Area of fragmentsc Linkage type
FSHW SM-FSHW IHW SM-IHW
2,3,4,6-Me4-Glc 22.66 32.0 6.8 20.5 Trd Glcp-(1→3→)-Glcp-
(1→3,6→)-Glcp-(1→2,4,6-Me3-Glc 24.45 36.4 86.7 59.1 99.8
2,4-Me2-Glc 25.05 31.6 6.5 20.3 –
a GC–MS analysis on a CP-Sil-43CB capillary column.
r
l
w
H
o
i
g
t
T
b
0
a
1
F
ab Retention time (min).
c Based on derived O-methyalditol acetates.
d Trace.
ecovered from hot aqueous extracts by ethanol precipitation, fol-
owed by centrifugation and dialysis of the precipitate against tap
ater. The solution was then freeze-dried to give rise to fraction
W (Fig. 1A).
Fractionation and puriﬁcation of HW crude extract was  carried
ut by a freeze–thawing procedure (Gorin & Iacomini, 1984), result-
ng in the respective cold water-soluble SHW (1.63 g, 3.9%) and a
el-like insoluble fraction, IHW (0.195 g, 0.5%).
Fraction  SHW gave heterogeneous HPSEC elution proﬁle;
herefore it was puriﬁed by treatment with Fehling solution.
he respective soluble fraction FSHW (0.560 g, 1.3%) showed to
e homogeneous on HPSEC, with Mw 1.13 × 105 g mol−1 (dn/dc
.157 mL  g−1) (Fig. 1B). While the water-insoluble IHW can be
ssumed as puriﬁed fraction based on its chemical composition,
3C NMR  and methylation data.
ig. 2. 13C NMR spectra of glucan fractions, FSHW (A) and IHW (B) with inserts of DEPT 
t 70 ◦C (chemical shifts are expressed in ı ppm).Each puriﬁed polysaccharide fraction contained only glucose as
its monosaccharide component (GC–MS). Analysis by GC–MS of
their partially O-methylated alditol acetates suggested the exist-
ence of two  branched (1→3),(1→6)-linked -d-glucans due to
the presence of 2,3,4,6-Me4-Glc, 2,4,6-Me3-Glc, and 2,4-Me2-Glc,
determined in molar ratio of 1:1.2:1 (FSHW) and 1:3:1 (IHW),
respectively (Table 1). These data reﬂect the difference observed
on solubility among the fractions, showing that soluble -d-glucan
is more branched than the insoluble one.
Fractions FSHW and IHW were examined using NMR  spec-
troscopy and signals were assigned using 1D (1H, 13C, and
DEPT-135) and 2D NMR  spectra (1H (obs.) 13C HMQC and
COSY). All the signals were compared to literature values for
similar polysaccharides (Carbonero et al., 2006, 2012; Smiderle
et al., 2006; Smiderle, Olsen, Carbonero, Baggio, et al., 2008;
CH2 inversion (A′ and B′ , respectively); -d-glucans, in D2O (A) and Me2SO-d6 (B)
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abata, Ito, & Kojima, 1981; Yoshioka, Tabeta, Saito, Uehara,
 Fukuoka, 1985).
13C NMR  (Fig. 2) and 1H (obs.), 13C HMQC spectra (Fig. 3) of
-d-glucan obtained from soluble fraction FSHW (Figs. 2A and 3)
ontained three distinct signals in the anomeric region at ı
03.0/4.30, 102.9/4.51 and 102.7/4.56, corresponding to non-
educing end, 3-O- and 3,6-di-O-substituted residues, respectively.
hile for the insoluble gel-like fraction (IHW) only two signals
ould be assigned at ı 103.1/4.21 corresponding to non-reducing
nd units, and at ı 102.9/4.51 from 3-O- and 3,6-di-O-substituted
esidues (Figs. 2B and 3). The -conﬁguration was  conﬁrmed by
he low-frequency of H-1 (ı 4.56, 4.51, 4.30 and 4.21) and high-
requency C-1 signals (ı 103.1, 102.9 and 102.7) (Figs. 2 and 3) (Hall
 Johnson, 1969).
The  glycosidic linkages of these glucans were shown by the pres-
nce of 3-O-substituted signals at ı 85.4, 85.1 and 84.9 for FSHW
Fig. 2A) and at ı 86.6, 86.3, and 86.0 for IHW (Fig. 2B). The O-
 substitution was conﬁrmed from the respective inverted peak
n the DEPT-135 spectra (Fig. 2A′ and B′). O-Substituted C-6 sig-
als downﬁeld at ı 68.8 (FSHW) and at  68.2 (IHW-Lr) appeared
s a doublet in HMQC at ı 68.8; 3.98/3.66 (Fig. 3A) and at ı 68.2;
.05/3.54 (Fig. 3B), respectively.
The backbone structures of the two isolated glucans were
haracterized by controlled Smith degradation, and their resid-
al polysaccharide products (SM-FSHW and SM-IHW, respectively)
ere analyzed by 13C NMR  (Fig. 4) spectroscopy and 1H (obs.)
3C HMQC (data not shown). It can be assumed that each frac-
ion has a linear main-chain formed by (1→3)-linked -d-glucan,
ue to the presence of typical C/H signals at ı 102.9/4.43 (C-1/H-
); 86.1/3.40 (C-3/H-3); 76.3/3.18 (C-5/H-5); 72.8/3.23 (C-2/H-2);
8.4/3.18 (C-4/H-4), and 60.9/3.69;3.40 (C-6/H-6a;b) (Gorin, 1981).
n the degraded fraction of the soluble glucan (SM-FSHW), low
ntensity signals from O-6 substitution were still present (Fig. 4A),
howing that this glucan is mostly substituted at O-6 by single-
nits of -d-Glcp and a minor proportion by side chains of
-O-substituted -d-glucopyranosyl oligosaccharides.
The products of controlled Smith degradation were analyzed
y methylation, and resulting alditol GC–MS analysis gave almost
xclusively a 2,4,6-Me3-glucitol derivative for IHW (99.8%; Table 1),
ndicating that the substitution occurs by single-units of glucose.
hese results further conﬁrm that the non-reducing end units of -
-Glcp, attached to the main-chain, were completely oxidized by
eriodate. On the other hand, and conﬁrming the NMR  data, thein D2O (A) and Me2SO-d6 (B) at 70 ◦C (chemical shifts are expressed in ı ppm).
soluble fraction contained not only substitutions by nonreducing
end-units, but it was also substituted by (1→3)-linked -d-Glcp
side chains (Table 1). To identify the extension of the few side
chains, FSHW was  submitted to a new round of controlled Smith
degradation. Three cycles of oxidation were required for their com-
plete removal to produce a linear polysaccharide formed only by
its main chain (SM3-FSHW), so probably, the side chains have a
maximum of three (1→3)-linked -d-Glcp units. This structure was
further used to compare its biological potential to those of isolated
-glucans, IHW and FSHW, obtained from L. rufus.
The results therefore suggest that the insoluble glucan (IHW)
is very similar to the puriﬁed glucans from Boletus erythropus
(Chauveau, Talaga, Wieruszeski, Strecker, and Chavant, 1996), Pleu-
rotus ﬂorida (Santos-Neves et al., 2008), Pleurotus eryngii and
Pleurotus ostreatoroseus (Carbonero et al., 2006), Pleurotus ostrea-
tus (Yoshioka et al., 1985), Pleurotus pulmonarius (Smiderle, Olsen,
Carbonero, Baggio, et al., 2008) and also from Flammulina velutipes
fruiting bodies (Smiderle et al., 2006). In contrast, the water-soluble
glucan (FSHW) appears to be different from other mushroom
(1→3),(1→6)-linked -d-glucans.
In conclusion, the results of monosaccharide composition,
methylation data, NMR  spectroscopic analysis, and controlled
Smith degradation of the studied fractions showed the presence
of -d-glucans with a (1→3)-linked main chain. These can be par-
tially substituted at O-6 by non-reducing end units of -d-Glcp as
side-chains, on the average to every fourth residue of the backbone
for the insoluble one (IHW) or partially substituted at O-6 mostly by
single-units of -d-Glcp and a minor proportion by 3-O-substituted
-d-glucopyranosyl oligosaccharides for soluble sample (FSHW).
3.2.  Effect of FSHW, IHW and SM3-FSHW on nociception induced
by intraplantar injection of formalin
It has been demonstrated that different polysaccharides isolated
from mushrooms display a variety of biological activities, includ-
ing antinociceptive and anti-inﬂammatory effects. Among these are
heterogalactans and glucans (Carbonero et al., 2008; Komura et al.,
2010; Queiroz et al., 2010; Smiderle, Olsen, Carbonero, Baggio, et al.,
2008; Ruthes et al., 2013).The formalin test is a model of sustained peripheral damage
frequently used to search for drugs with antinociceptive or anti-
inﬂammatory activities (Tjølsen, Berge, Hunskaar, Rosland, & Hole,
1992). In addition, the injection of formalin gives rise to an early
134 A.C.  Ruthes et al. / Carbohydrate Polymers 94 (2013) 129– 136
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pm).
hase (1–5 min  after injection, approximately) and a late phase
15–60 min  approximately) of pain sensation in humans and noci-
eptive behavior in animals (Porro & Cavazzuti, 1993; Tjølsen
t al., 1992). Furthermore, spinal nociceptive neurons with recep-
ive ﬁelds in the injected paw show corresponding early and late
hases of ﬁring (Dickenson & Sullivan, 1987). The early phase of
he formalin response is due to the excitation of spinal cord neu-
ons by a barrage of afferent impulses. The late phase is due to
he effect of lingering afferent impulses upon spinal neurons that
ave now become hyper excitable due to the release of neuroactive
ediators, and is thus regarded as a model of central sensitiza-
ion (Hunskaar & Hole, 1987; Porro & Cavazzuti, 1993; Tjølsen
t al., 1992). Thus, it has been shown that injection of formalin
vokes a signiﬁcant increase in the spinal cord concentration of
europeptides, excitatory amino acids (glutamate and aspartate),
itric oxide, and pro-inﬂammatory mediators (Porro & Cavazzuti,
993; Tjølsen et al., 1992).
We now, in order to evaluate the biological action of the -
lucans isolated from L. rufus, tested them on the nociception
nduced by formalin, an inﬂammatory pain model, which has a
ood correlation with the pain that occurs in humans. The results
emonstrated that intraperitoneal administration of FSHW, IHW
nd SM3-FSHW, at doses of 30 mg  kg−1, reduced the neurogenic
ain (early phase) with inhibition of 36 ± 8%, 47 ± 13%, and 58 ± 4%,
espectively (Fig. 5A, C and E). However, these polysaccharide sam-
les were more effective against inﬂammatory pain (late phase) of
ormalin-induced nociception, with inhibition of 99 ± 1%, 96 ± 3%,
nd 80 ± 9%, respectively (Fig. 5B, D and F). Moreover, it is signiﬁ-
ant that the polysaccharide fraction, FSHW, which is soluble and
ore branched, was signiﬁcantly more potent than IHW (insolu-
le glucan and less branched) and SM3-FSHW (modiﬁed glucan,
ith linear structure) to inhibit the late phase of formalin-induced
ociception (Fig. 5B, D and F), with ID50 values of 2.35 (1.48–3.75),
0.83 (9.27–12.63) and 10.56 (6.54–17.04) mg  kg−1, respectively.
n the other hand, also at doses of 30 mg  kg−1 exactly the contrary
ccurred in the early phase, relative to neurogenic phase (Fig. 5A, C
nd E), where linear -glucan (SM3-FSHW) had a major inhibitory; A and B, respectively), in Me2SO-d6 at 70 ◦C (chemical shifts are expressed in ı
effect,  when compared to IHW and FSHW glucans, with intermedi-
ary and greater branching degree, respectively.
The neurogenic pain inhibition observed for IHW (47 ± 13%),
showed to be very close to that observed for a structurally similar
-glucan isolated from P. pulmonarius (43 ± 5%) also at 30 mg  kg−1
(Smiderle, Olsen, Carbonero, Baggio, et al., 2008). The same com-
parison could be done with the late phase results, where IHW
inhibit 96 ± 3% formalin-induced nociception, as well as observed
for P. pulmonarius -glucan (96 ± 4%) (Smiderle, Olsen, Carbonero,
Baggio, et al., 2008). Such a relationship cannot be undertaken for
the soluble glucan (FSHW) or the linear product obtained after
three cycles of controlled Smith degradation (SM3-FSHW), since
these structures are being ﬁrst described. Thus, they were not pre-
viously assessed for their potential as possible biological response
modiﬁers.
4. Discussion
-Glucans have been extensively studied regarding their iso-
lation and structural characterization. Such research showed
remarkable biological properties, mostly antitumor, attributed to
these polysaccharides. Hot water extracts from edible mushrooms
have been used for a long time in traditional oriental medicine,
as antitumor, anti-infective and anti-inﬂammatory drugs. Later
research established that such biological activity is mainly due
to the presence of -glucans having common structure of (l→3)-
linked backbone with single glucosyl units attached to the
main-chain through (l→6)-glycosidic linkage (Kogan, 2000).
As  biological response modiﬁers, -glucans action is mediated
through the organism’s own  defense tools. Such host-mediated
defense is advantageous in comparison with the traditional
approach of using synthetic or semi-synthetic therapeutics, once
-glucans are non-toxic to the host organism cells (Kogan, 2000).Some  studies have indicated that the distribution of the single
glucosyl units along the main chain confers their immunomodulat-
ing activity, with their solubility in water also being important for
biological applications (Bohn & BeMiller, 1995). Thus, the soluble
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)  in mice. Each column represents the mean 4–6 animals ± S.E.M. Control values (
sterisks denote the signiﬁcance levels when compared with the control group; *p <
-d-glucan of L. rufus could be considered as a good candidate for
valuation of analgesic and anti-inﬂammatory potential.
Several research groups have tested mushroom extracts hav-
ng anti-inﬂammatory and antinociceptive effects (Diyabalanage,
ulabagal, Mills, DeWitt, & Nair, 2008; Dore et al., 2007; Lin, Chen,
hiang, & Lin, 2006; Liu et al., 2007; Moro et al., 2012; Park et al.,
005; Queiroz et al., 2010; Wu,  Duan, Liu, & Cen, 2010). However,
he bioactive molecule(s) could not be identiﬁed. Studies evaluat-
ng such effects with pure mushroom polysaccharides are still few.
eterogalactans are the most studied polysaccharides regarding to
ntinociceptive and anti-inﬂammatory potential (Carbonero et al.,
008; Komura et al., 2010; Ruthes et al., 2013; Smiderle, Olsen,
arbonero, Marcon, et al., 2008).
P. pulmonarius (1→3),(1→6)-linked -glucan, which showed
nti-inﬂammatory and analgesic properties (Baggio et al., 2010,
012; Smiderle, Olsen, Carbonero, Baggio, et al., 2008) contain the
losest structure to which obtained results could be related, once
ts chemical structure is very similar to that of the -glucan char-
cterized from fraction IHW.
However, the soluble glucan is now shown to have a structure
ith a higher degree of branching, having not only being substi-
uted by single Glcp units, but also by some (1→3)-linked Glcp side
hains, making it different from all other glucans already having
heir biological potential evaluated.
The formalin test was chosen for being a widely used model of
ersistent pain and a mainstay for novel drug development for the
reatment of postoperative pain (Shields et al., 2010). The test can
e divided into two distinct phases. The ﬁrst is characterized by
eurogenic pain caused by direct chemical stimulation of nocicep-
ors. The second is characterized by inﬂammatory pain triggered
y a combination of stimuli, including peripheral tissue inﬂamma-
ion and mechanisms of central sensitization (Tjølsen et al., 1992).
n the formalin test, FSHW, IHW and SM3-FSHW showed a greater
nhibition in the second phase than in the ﬁrst, suggesting that its
ntinociceptive effect is related to inﬂammatory pain.
Therefore, our results demonstrate that the -glucans (FSHW,
HW and SM3-FSHW) tested have an activity similar to those
f non-steroidal anti-inﬂammatory, once they did not producedinduced nociception (early phase, panels A, C and E; and late phase, panels B, D and
icate the animals injected with saline or vehicle (saline plus 5% Tween 80) and the
 **p < 0.01 and ***p < 0.001 (one-way ANOVA followed by the Newman–Keuls test).
profound  effects on the ﬁrst phase of intraplantar injection of
formalin, but showed signiﬁcant inhibition in the second phase
response (Malmberg & Yaksh, 1992; Smiderle, Olsen, Carbonero,
Baggio, et al., 2008).
Furthermore, it was clearly observed that L. rufus -glucans
branching degree and mainly the polysaccharides sample solubility
seems to be important for their antinociceptive effect in response
for both, neurogenic and inﬂammatory pain, but inversely. In the
future, more experiments are necessary to identify the speciﬁc
mechanism behind this inhibition of inﬂammation.
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